Trokendi XR is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to control partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in people six years of age and older. Trokendi XR is also referred to by its drug name, topiramate.
Trokendi XR is an anticonvulsant, or in other words, drug used to prevent and control seizures. It is believed to work in cases of epilepsy by inhibiting nerve signals in the brain.
How do I take it?
Prescribing information states that Trokendi XR is taken orally as an extended-release capsule once daily.
The FDA-approved label for Trokendi XR lists common side effects including “pins-and-needles” sensations, loss of appetite, weight loss, speech problems, fatigue, dizziness, sleepiness, nervousness, slowing of thought and body movement, abnormal vision, and fever.
Rare but serious side effects listed for Trokendi XR include cognitive dysfunction, kidney stones, increased or lowered body temperature, high body acid levels, suicidal thoughts and behavior, fetal harm, and severe eye problems potentially leading to permanent vision loss.
For more details about this treatment, visit:
Trokendi XR — Supernus
Trokendi XR — RxList